Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2019 Novel Coronavirus”

447 trials

Showing 20 of 447 results

Testing effectiveness (Phase 2)Study completedNCT04566770
What this trial is testing

A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)

Who this might be right for
COVID-19
CanSino Biologics Inc. 480
Testing effectiveness (Phase 2)UnknownNCT05047783
What this trial is testing

Masitinib in Patients With Symptomatic Mild to Moderate COVID-19

Who this might be right for
Covid19SARS-CoV2 InfectionCoronavirus Disease 2019
AB Science 78
Testing effectiveness (Phase 2)UnknownNCT05205083
What this trial is testing

Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of BBIBP-CorV

Who this might be right for
COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 480
Testing effectiveness (Phase 2)Ended earlyNCT04365257
What this trial is testing

Prazosin to Prevent COVID-19 (PREVENT-COVID Trial)

Who this might be right for
COVID-19
Johns Hopkins University 5
Not applicableEnded earlyNCT04261907
What this trial is testing

Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection

Who this might be right for
2019-nCoV
First Affiliated Hospital of Zhejiang University 6
Not applicableUnknownNCT04465474
What this trial is testing

Coronavirus Disease 2019 (COVID-19) During Pregnancy: Prevalence of Seroconversion, Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission (COVID-MAP)

Who this might be right for
COVID-19
Chinese University of Hong Kong 3,000
Early research (Phase 1)Study completedNCT04961359
What this trial is testing

Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2（COVID-19） Phase I Clinical Trial (3~17 Years Old)

Who this might be right for
Coronavirus
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 75
Testing effectiveness (Phase 2)Ended earlyNCT04342897
What this trial is testing

LY3127804 in Participants With COVID-19

Who this might be right for
COVID-19Pneumonia
Eli Lilly and Company 95
Not applicableStudy completedNCT04925908
What this trial is testing

Exclusive Breastfeeding in Infants of Mothers Infected With Novel Coronavirus

Who this might be right for
Covid19Breastfeeding, ExclusiveNewborn Morbidity
Kanuni Sultan Suleyman Training and Research Hospital 338
Testing effectiveness (Phase 2)Study completedNCT04566276
What this trial is testing

ChulaCov19 Vaccine in Healthy Adults

Who this might be right for
COVID-19 VaccineSafety Issues
Chulalongkorn University 192
Not applicableUnknownNCT04273646
What this trial is testing

Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19

Who this might be right for
2019 Novel Coronavirus PneumoniaCOVID-19
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 48
Testing effectiveness (Phase 2)Study completedNCT04380688
What this trial is testing

Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.

Who this might be right for
COVID-19
AstraZeneca 62
Post-approval studies (Phase 4)UnknownNCT04856111
What this trial is testing

Pirfenidone vs. Nintedanib for Fibrotic Lung Disease After Coronavirus Disease-19 Pneumonia

Who this might be right for
Novel Coronavirus-induced Lung Fibrosis
Post Graduate Institute of Medical Education and Research, Chandigarh 48
Testing effectiveness (Phase 2)UnknownNCT06288893
What this trial is testing

SHEN211 Tablets for the Treatment of Mild and Moderate Novel Corona Virus Infections (COVID-19)

Who this might be right for
COVID-19
JKT Biopharma Co., Ltd. 30
Not applicableActive Not RecruitingNCT04262921
What this trial is testing

French COVID Cohort

Who this might be right for
Coronavirus Infections
Institut National de la Santé Et de la Recherche Médicale, France 4,415
Post-approval studies (Phase 4)Looking for participantsNCT07266558
What this trial is testing

Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 30,000
Not applicableStudy completedNCT05104411
What this trial is testing

Rehabilitation in Severely Ill Inpatients With COVID-19

Who this might be right for
COVID-19
Seoul National University Bundang Hospital 37
Not applicableStudy completedNCT05124548
What this trial is testing

Sleep Characteristics in Post-COVID-19 Patients

Who this might be right for
Post-COVID-19
Schön Klinik Berchtesgadener Land 31
Early research (Phase 1)Ended earlyNCT04638634
What this trial is testing

Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
CSL Behring 12
Not applicableStudy completedNCT07072793
What this trial is testing

A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe

Who this might be right for
COVID-19 (Coronavirus Disease 2019)
Pfizer 131,005
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation